Brand / product

Symbidow

Budesonide + Formoterol · 400 mcg + 12 mcg

ShareSend this page
₨ Official source-observed price PKR 738.64 30's
PKR 24.62 / capsule
✓ Official DRAP price source observed · Source checked 2026-11-13
Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 24.62/ capsule
Price position10% below medianvs like-for-like peer median
Peer comparators11current-price listings
🔒
MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence
View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic
Budesonide + Formoterol
Therapeutic area
Respiratory & allergy
Drug class
Inhaled controller therapy
ATC
R03AK
Strength
400 mcg + 12 mcg
Dosage form
Inhalation capsule
Pack
30's
Registration no.
107791
Price record verified
2026-08-09
Latest DRAP source check
2026-11-13 03:02

Manufacturer

Martin Dow Limited

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

What Symbidow (Budesonide + formoterol) is used for

Budesonide with formoterol is a combination inhaler for the lungs that holds two medicines. Budesonide is a steroid (corticosteroid) that calms swelling and irritation inside the airways. Formoterol is a long-acting bronchodilator (a long-acting beta agonist) that relaxes the muscles around the airways so they stay open for longer. Together they help control breathing problems, but they do not cure asthma or COPD. It is a prescription medicine and comes in several types of inhaler device. WHO lists it as an essential medicine for asthma.

  • Asthma: to prevent and control symptoms such as wheezing, coughing, chest tightness and breathlessness
  • Chronic obstructive pulmonary disease (COPD) in adults, sometimes together with other inhalers that open the airways
  • In some asthma plans, as both the regular preventer and the reliever for sudden symptoms. This is called maintenance and reliever therapy (MART). Only some products and plans work this way, so follow your own asthma plan.
  • It is used mainly by adults and teenagers. Some products are only for adults; check the leaflet for your inhaler.

Get medical help straight away if

  • If you suddenly wheeze or become more breathless straight after using the inhaler, use your reliever inhaler at once and get medical help. Do not use this inhaler again unless a doctor tells you to.
  • Call an ambulance or go to the emergency department for signs of a severe allergic reaction: swelling of the face, lips, mouth, tongue or throat, trouble breathing or swallowing, hives with breathing problems, or sudden faintness.
  • Get urgent medical help for chest pain, fainting, or a very fast, pounding or uneven heartbeat.
  • Contact a doctor straight away for signs of a chest infection: fever or chills, more phlegm or a change in its colour, or a worse cough or breathing.

Side effects, warnings and interactions for Budesonide + formoterol

Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.

Our condition guides that mention Budesonide + Formoterol

From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Budesonide + Formoterol is right for you and the dose.

  • Asthma: preferred single inhaler used as a reliever when needed and, at higher steps, also as regular maintenance (MART)
  • Chronic obstructive pulmonary disease (COPD): added for people who keep having flare-ups and have raised blood eosinophils, usually alongside a long-acting antimuscarinic
Summary

About Symbidow 400 mcg + 12 mcg inhalation capsule

Symbidow 400 mcg + 12 mcg inhalation capsule contains Budesonide + Formoterol 400 mcg + 12 mcg. It is registered with DRAP by Martin Dow Limited (registration no. 107791). Its official price is PKR 738.64 for a pack of 30's, about PKR 24.62 per capsule. This price has applied since 22 July 2026. Symbidow is also available as 200 mcg + 6 mcg inhalation capsule. 8 other brands of Budesonide + Formoterol 400 mcg + 12 mcg (inhalation capsule) are registered in Pakistan. Compare all brands and prices →

Same brand

Other strengths of Symbidow

Alternatives (substitutes): same medicine, strength and form

All 8 other brands of Budesonide + Formoterol 400 mcg + 12 mcg inhalation in Pakistan

These 8 brands are alternatives (substitutes) to Symbidow: each contains Budesonide + Formoterol 400 mcg + 12 mcg inhalation. Ask your doctor or pharmacist before you switch brands.

Sorted by price per capsule, lowest first. The lowest is Combivair Forte (Highnoon Laboratories Ltd) at PKR 23.01 per capsule; the highest is Busonide at PKR 31.58. All prices are official DRAP prices.

BrandCompanyPackOfficial pricePer unit
Combivair ForteHighnoon Laboratories Ltd30PKR 690.31PKR 23.01 / capsule
B-Form DSScilife Pharma Private Limited30'sPKR 738.63PKR 24.62 / capsule
VenticortMacter International Limited3 x 10'sPKR 823.93PKR 27.46 / capsule
FormigetGetz Pharma (Pvt) Limited30'sPKR 911.78PKR 30.39 / capsule
Famtrol BD DPIM/s. Genix Pharma (Pvt) Ltd3x10'sPKR 917.54PKR 30.58 / capsule
SymbiventHudson Pharma (Pvt) Ltd3 x 10'sPKR 917.56PKR 30.59 / capsule
BudenoxHorizon Healthcare (pvt.) ltd30'sPKR 917.56PKR 30.59 / capsule
BusonidePHARMEVO (PVT) LTD30'sPKR 947.52PKR 31.58 / capsule

See every strength and form of Budesonide + Formoterol →

Where to buy

MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Symbidow, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.

Registration holder
Martin Dow Limited, Karachi
DRAP registration
107791
Phone
+92 21 111 111 634
Email
info@martindow.com
Website
https://www.martindowltd.com/
Contact page
Company contact page

Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.

Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (30's). Current price PKR 738.64, effective 22 Jul 2026.

Cite this price history

MedInfoBase. Symbidow 400 mcg + 12 mcg, 30's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/symbidow-400-mcg-12-mcg-107791-30s-martin-dow-limited/ (accessed 13 November 2026).

Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 738.642026-07-222026-09-22DRAP PharmaPrice Index (recovered from snapshot #84)Current
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 107791
MedInfoBase. (2026). Symbidow 400 mcg + 12 mcg Inhalation capsule (30's), Martin Dow Limited — registration and price record [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/brand/symbidow-400-mcg-12-mcg-107791-30s-martin-dow-limited/ Data observed 22 September 2026. Source: DRAP PharmaPrice Index (recovered from snapshot #84). DRAP registration 107791.
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9